Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04205968
Title Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Southwest Oncology Group
Indications

small intestine cancer

Therapies

Fluorouracil + Irinotecan + Leucovorin

Paclitaxel + Ramucirumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.